Skip to main content
. 2016 Jul 12;19(3):258–263. doi: 10.1038/pcan.2016.7

Figure 2.

Figure 2

Transperineal mapping (TPM) histological findings per patient within the Prostate Mri Imaging Study (PROMIS) trial are resumed by a full report and by a visual report. In the full report (a), each core is labelled per coordinate and the following details are displayed: core length, cancer status, cumulative and separate cancer core length (CCL), cancer position, primary, secondary and tertiary Gleason grade, perineural and lymphovascular invasion as well as the presence of inflammation, high-grade PIN and ASAP. The TPM visual report (b) provides immediate zonal location within the gland. Maximum CCL and colour-coded risk attribution are displayed per coordinate with white boxes representing prostate biopsies with no cancer. ASAP, atypical small acinar proliferation; PIN, prostatic intraepithelial neoplasia.